Pandemic whole-virion, Vero-cell-derived, adjuvant-free influenza A H1N1 vaccine in patients with solid tumors and hematologic malignancies receiving concurrent anticancer treatment: Immunogenicity, tolerability, and acceptability during the pandemic situation

Lagler, Heimo; Tobudic, Selma; Ramharter, Michael; Elandt, Katarzyna; Sperr, Wolfgang R.; Redlberger-Fritz, Monika; Popow-Kraupp, Theresia; Jaeger, Ulrich; Zielinski, Christoph C.; Burgmann, Heinz

dc.contributor.author	Ramharter, Michael	de_DE
dc.date.accessioned	2014-03-04T08:59:34Z
dc.date.available	2014-03-04T08:59:34Z
dc.date.issued	2012	de_DE
dc.identifier.issn	0264-410X	de_DE
dc.identifier.uri	http://hdl.handle.net/10900/42805
dc.language.iso	en	en
dc.publisher	Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.vaccine.2012.09.005	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Pandemic whole-virion, Vero-cell-derived, adjuvant-free influenza A H1N1 vaccine in patients with solid tumors and hematologic malignancies receiving concurrent anticancer treatment: Immunogenicity, tolerability, and acceptability during the pandemic situation	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140226071329_00412	de_DE
utue.publikation.seiten	6864-6870	de_DE
utue.personen.roh	Lagler, Heimo	de_DE
utue.personen.roh	Tobudic, Selma	de_DE
utue.personen.roh	Ramharter, Michael	de_DE
utue.personen.roh	Elandt, Katarzyna	de_DE
utue.personen.roh	Sperr, Wolfgang R.	de_DE
utue.personen.roh	Redlberger-Fritz, Monika	de_DE
utue.personen.roh	Popow-Kraupp, Theresia	de_DE
utue.personen.roh	Jaeger, Ulrich	de_DE
utue.personen.roh	Zielinski, Christoph C.	de_DE
utue.personen.roh	Burgmann, Heinz	de_DE
dcterms.isPartOf.ZSTitelID	Vaccine	de_DE
dcterms.isPartOf.ZS-Issue	48	de_DE
dcterms.isPartOf.ZS-Volume	30	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE